KOA Biotech

KOA Biotech Analysis

KOA Biotech is a cutting-edge startup focused on revolutionizing disease management in aquaculture. With their digital, autonomous, and onsite testing technology, they aim to reduce fish mortality and lower costs by up to 50% in fish farms. Their innovative approach not only improves fish health and farm economics but also significantly reduces the environmental impact of aquaculture on a global scale.

Currently, more than 50% of the fish consumed worldwide comes from farms, and the existing testing technology involving the shipment of water samples to labs with a long turnaround time for results poses significant challenges. KOA Biotech's onsite testing kits, which continually monitor potentially harmful bacteria in water and create early warning alerts to prevent infections, are poised to revolutionize this aspect of the industry.

As a spinoff from the University of Pompeu Fabra, KOA Biotech benefits from the expertise of a group of PhDs in Biology. This academic background adds substantial credibility to their efforts. Moreover, with 2 live tests already running and 8 more letters of intent in the pipeline for the next three months, the startup is making substantial strides in terms of market validation and customer interest.

KOA Biotech operates at the intersection of agriculture, biotechnology, IoT, and AgriTech, with its headquarters located in Spain. The potential for the company to contribute to more sustainable food production is a compelling factor, aligning with the growing global focus on environmental responsibility and ethical food sourcing.

With a strong value proposition and significant market traction, KOA Biotech presents a promising investment opportunity for venture capitalists looking to support innovative solutions with a clear societal and environmental impact.